BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 25874486)

  • 1. High expression of DEC2 distinguishes chondroblastic osteosarcoma and promotes tumour growth by activating the VEGFC/VEGFR2 signalling pathway.
    Tuerxun M; Zheng X; Xu J; Yang Q; Yuan T; Zhang C; Zhou S
    J Cell Mol Med; 2024 Jun; 28(11):e18462. PubMed ID: 38847478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation.
    Wei R; Cao Y; Wu H; Liu X; Jiang M; Luo X; Deng Z; Wang Z; Ke M; Zhu Y; Chen S; Gu C; Yang Y
    Aging (Albany NY); 2023 Aug; 15(16):8220-8236. PubMed ID: 37606987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression.
    Yoo S; Sinha A; Yang D; Altorki NK; Tandon R; Wang W; Chavez D; Lee E; Patel AS; Sato T; Kong R; Ding B; Schadt EE; Watanabe H; Massion PP; Borczuk AC; Zhu J; Powell CA
    Nat Commun; 2022 Mar; 13(1):1592. PubMed ID: 35332150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel Aurora B inhibitor GSK650394 with potent anticancer and anti-
    He Y; Fu W; Du L; Yao H; Hua Z; Li J; Lin Z
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):109-117. PubMed ID: 34894976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screening.
    Hongo H; Kosaka T; Suzuki Y; Oya M
    Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):59-66. PubMed ID: 34593983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
    Costantini S; Capone F; Polo A; Bagnara P; Budillon A
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological function and clinical significance of STIL in osteosarcoma.
    Ji SF; Wen SL; Sun Y; Huang PW; Wu H; He ML
    Cancer Cell Int; 2021 Apr; 21(1):218. PubMed ID: 33858425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora-B knockdown inhibits osteosarcoma metastasis by inducing autophagy via the mTOR/ULK1 pathway.
    Wu X; Liu JM; Song HH; Yang QK; Ying H; Tong WL; Zhou Y; Liu ZL
    Cancer Cell Int; 2020 Nov; 20(1):575. PubMed ID: 33292257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B.
    Yu JJ; Pi WS; Cao Y; Peng AF; Cao ZY; Liu JM; Huang SH; Liu ZL; Zhang W
    Cancer Manag Res; 2018; 10():6305-6315. PubMed ID: 30568492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq.
    Yang Y; Zhang Y; Qu X; Xia J; Li D; Li X; Wang Y; He Z; Li S; Zhou Y; Xie L; Yang Z
    Oncotarget; 2016 Dec; 7(52):87194-87205. PubMed ID: 27888627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones.
    Macklin R; Wang H; Loo D; Martin S; Cumming A; Cai N; Lane R; Ponce NS; Topkas E; Inder K; Saunders NA; Endo-Munoz L
    Oncotarget; 2016 Jul; 7(28):43570-43587. PubMed ID: 27259278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.
    Schweitzer K; Pralow A; Naumann M
    J Cell Mol Med; 2016 Jan; 20(1):58-70. PubMed ID: 26463447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Aurora-B alters osteosarcoma cell malignant phenotype via decreasing phosphorylation of VCP and NF-κB signaling.
    He JY; Xi WH; Zhu LB; Long XH; Chen XY; Liu JM; Luo QF; Zhu XP; Liu ZL
    Tumour Biol; 2015 May; 36(5):3895-902. PubMed ID: 25874486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Molecular Mechanisms of AURKB in the Oncogenesis and Progression of Osteosarcoma Cells: A Label-Free Quantitative Proteomics Analysis.
    Pi WS; Cao ZY; Liu JM; Peng AF; Chen WZ; Chen JW; Huang SH; Liu ZL
    Technol Cancer Res Treat; 2018; 18():1533033819853262. PubMed ID: 31122179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.
    Zhu LB; Jiang J; Zhu XP; Wang TF; Chen XY; Luo QF; Shu Y; Liu ZL; Huang SH
    Int J Clin Exp Pathol; 2014; 7(7):3984-91. PubMed ID: 25120775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting valosin-containing protein suppresses osteosarcoma cell metastasis via AKT/nuclear factor of kappa B signaling pathway in vitro.
    Long XH; Zhang ZH; Liu ZL; Huang SH; Luo QF
    Indian J Pathol Microbiol; 2013; 56(3):190-5. PubMed ID: 24152492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP).
    Long XH; Zhou YF; Peng AF; Zhang ZH; Chen XY; Chen WZ; Liu JM; Huang SH; Liu ZL
    Tumour Biol; 2015 May; 36(5):3799-806. PubMed ID: 25566966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Let-7g reverses malignant phenotype of osteosarcoma cells by targeting Aurora-B.
    Liu JM; Long XH; Zhang GM; Zhou Y; Chen XY; Huang SH; Liu ZL; Zhang ZH
    Int J Clin Exp Pathol; 2014; 7(8):4596-606. PubMed ID: 25197332
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.